Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Lafutidine

SKU: orb1226861

Description

Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion.(In Vitro):Lafutidine exhibits gastric mucosal protective action mediated by capsaicin-sensitive afferent neurons, in addition to a potent antisecretory effect.Lafutidine (0.1-10 μM) significantly augments the periarterial nerve stimulation (PNS, 1 Hz) induced-vasodilation in a concentration-dependent manner in rat perfused mesenteric vascular beds.(In Vivo):Lafutidine (3-30 mg/kg; p.o.; twice daily; for 6 days) dose-dependently reduces the severity of dextran sulfate Na (DSS)-induced colitis and significantly mitigates changes in the colon length and myeloperoxidase (MPO) activity.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number118288-08-7
MW431.55
Purity>98% (HPLC)
FormulaC22H29N3O4S
SMILESC1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3
Target5-HT Receptor
SolubilityEthanol: 13 mg/mL (30.12 mM); DMSO: 86 mg/mL (199.28 mM)

Bioactivity

In Vivo
Lafutidine (3-30 mg/kg; p.o. ; twice daily; for 6 days) dose-dependently reduces the severity of dextran sulfate Na (DSS)-induced colitis and significantly mitigates changes in the colon length and myeloperoxidase (MPO) activity. Animal model: Male Wistar rats (180-200 g). Dosage: 3 mg/kg, 10 mg/kg, 30 mg/kg. Administration: Oral administration, twice daily, for 6 days. Result: Reduced the severity of DSS-induced ulcerative colitis in a dose-dependent manner.
In Vitro
Lafutidine exhibits gastric mucosal protective action mediated by capsaicin-sensitive afferent neurons, in addition to a potent antisecretory effect. Lafutidine (0.1-10 μM) significantly augments the periarterial nerve stimulation (PNS, 1 Hz) induced-vasodilation in a concentration-dependent manner in rat perfused mesenteric vascular beds.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Lafutidine [orb1310959]

    98.55% (May vary between batches)

    118288-08-7

    431.55

    C22H29N3O4S

    1 ml x 10 mM (in DMSO), 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Lafutidine (orb1226861)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
25 mg
$ 80.00
50 mg
$ 120.00
100 mg
$ 170.00